Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients

Cancer Research

Volumn 58, Issue 3, 1998, Pages 512-518

  Narimatsu, Hisashi ^a   Iwasaki, Hiroko ^a   Nakayama, Fumiaki ^a,b   Ikehara, Yuzuru ^a   Kudo, Takashi ^a   Nishihara, Shoko ^a   Sugano, Kokichi ^c   Okura, Hisanao ^c   Fujita, Shin ^c   Hirohashi, Setsuo ^d  

^a SOKA UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; CA 19-9 ANTIGEN; DUPAN 2; TUMOR MARKER;

ALLELE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE DOSAGE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ALLELES; ANTIGENS, NEOPLASM; CA-19-9 ANTIGEN; CARBOHYDRATE SEQUENCE; COLORECTAL NEOPLASMS; EPITOPES; FUCOSYLTRANSFERASES; GENE DOSAGE; GENOTYPE; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHENOTYPE; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR MARKERS, BIOLOGICAL;

EID: 18844468498     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Herlyn, M., Sears, H. F., Steplewski, Z., and Koprowski, H. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of the antigen in sera of patients with colorectal, gastric, and pancreatic carcinomas. J. Clin. Immunol., 2: 135-140, 1982.
2. Metzgar, R. S., Gaillard, M. T., Levine, S. J., Tuck, F. L., Bossen E. H., and Borowitz, M. J. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res., 42: 601-608, 1982.
3. Magnani, J. L., Nilson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., and Ginsburg, V. A. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentose II. J. Biol. Chem., 257: 14365-14369, 1982.
4. Hamanaka, Y., Hamanaka, S., Shinagawa, Y., Suzuki, T., Inagaki, F., Suzuki, M., and Suzuki, A. Ganglioside antigen of DU-PAN-2 in a human pancreatic cancer. FEBS Lett., 353: 48-52, 1994.
5. Elmgren, A., Rydberg, L., and Larson, G. Genotypic heterogeneity among Lewis negative individuals. Biochem. Biophys. Res. Commun., 196: 515-520, 1993.
6. Nishihara, S., Yazawa, S., Iwasaki, H., Nakazato, M., Kudo, T., Ando, T., and Narimatsu, H. The α-(1,3/1,4)fucosyltransferase gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals. Biochem. Biophys. Res. Commun., 196: 624-631, 1993.
7. Koda, Y., Kimura, H., and Mekada, E. Analysis of Lewis fucosyltransferase genes from the human gastric mucosa of Lewis-positive and -negative individuals. Blood, 82: 2915-2919, 1993.
8. Mollicone, R., Reguigne, I., Kelly, R. J., Fletcher, A., Watt, J., Chatfield, S., Aziz, A., Cameron, H. S., Weston, B. W., Lowe, J. B., and Oriol, R. Molecular basis for Lewis α(1,3/1,4)-fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian pedigrees. J. Biol. Chem., 269: 20987-20994, 1994.
9. Nishihara, S., Narimatsu, H., Iwasaki, H., Yazawa, S., Akamatsu, S., Ando, T., Seno, T., and Narimatsu, I. Molecular genetic analysis of the human Lewis histo-blood group system. J. Biol. Chem., 269: 29271-29278, 1994.
10. Elmgren, A., Börjeson, C., Svensson, L., Rydberg, L., and Larson, G. DNA sequencing and screening for point mutations in the human Lewis (FUT3) gene enables molecular genotyping of the human Lewis blood group system. Vox Sang., 70: 97-103, 1996.
11. Ørntoft, T. F., Vestergaard, E. M., Holmes, E., Jakobsen, J. S., Grunnet, N., Mortensen, M., Johnson, P., Bross, P., Gregersen, N., Skorstengaard, K., Jensen, U. B., Bolund, L., and Wolf, H. Influence of Lewis α1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels. J. Biol. Chem., 271: 32260-32268, 1996.
12. Rouquier, S., Lowe J. B., Kelly, R. J., Feritta, A. L., Lennon, G. G., and Giorgi, D. Molecular cloning of a human genomic region containing the H blood group α(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments: isolation of a candidate for the human secretor blood group locus. J. Biol. Chem., 270: 4632-4639, 1995.
13. Kudo, T., Iwasaki, H., Nishihara, S., Shinya, N., Ando, T., Narimatsu, I., and Narimatsu, H. Molecular genetic analysis of the human Lewis histo-blood group system. II. Secretor gene inactivation by a novel single missense mutation, A385T, in Japanese non-secretor individuals. J. Biol. Chem., 271: 9830-9837, 1996.
14. Henry, S., Mollicone, R., Fernandez, P., Samuelsson, B., Oriol, R., and Larson, G. Molecular basis for erythrocyte Le(a+ b+) and salivary ABH partial-secretor phenotypes: expression of a FUT2 secretor allele with an A→T mutation at nucleotide 385 correlates with reduced α(1,2)fucosyltransferase activity. Glycoconj. J., 13: 985-993, 1996.
15. Koda, Y., Soejima, M., Liu, Y., and Kimura, H. Molecular basis for secretor type α(1,2)-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency. Am. J. Hum. Genet., 59: 343-350, 1996.
16. Yu, L-C., Broadberry, R. E., Yang, Y-H., Chen, Y-H., and Lin, M. Heterogeneity of the human secretor α(1,2)fucosyltransferase gene among Lewis(a+ b-) non-secretors. Biochem. Biophys. Res. Commun., 222: 390-394, 1996.
17. Narimatsu, H., Iwasaki, H., Nishihara, S., Kimura, H., Kudo, T., Yamauchi, Y., and Hirohashi, S. Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme. Cancer Res., 56: 330-338, 1996.
18. Kono, M., Ohyama, Y., Lee, Y-C., Hamamoto, T., Kojima, N., and Tsuji, S. Mouse β-galactoside α2,3-sialyltransferases. comparison of in vitro substrate specificities and tissue specific expression. Glycobiology, 7: 469-479, 1997.
19. Kawa, S., Oguchi, H., Kobayashi, T., Tokoo, M., Furuta, S., Kanai, M., and Homma, T. Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for the Lewis blood group phenotype. Br. J. Cancer, 64: 899-902, 1991.
20. Yazawa, S., Nishihara, S., Iwasaki, H., Asao, T., Nagamachi, Y., Malta, K. L., and Narimatsu, H. Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients. Cancer Res., 55: 1473-1478, 1995.
21. Pour, P. M., Tempero, M. M., Takasaki, H., Uchida, E., Takiyama, Y., Burnett, D. A., and Steplewski, Z. Expression of blood-group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y. and CA19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res., 48: 5422-5426, 1988.
22. Hirano, K., Kawa, S., Oguchi, H., Kobayashi, T., Yonekura, H., Ogata, H., and Homma, T. Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels. J. Natl. Cancer Inst. (Bethesda), 79: 1261-1268, 1987.
23. Henry, S., Oriol, R., and Samuelsson, B. Lewis histo-blood group system and associated secretory phenotypes. Vox Sang., 69: 166-182, 1995.